These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32936722)

  • 1. Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.
    Saito Y; Takekuma Y; Komatsu Y; Sugawara M
    J Oncol Pharm Pract; 2021 Jun; 27(4):1020-1025. PubMed ID: 32936722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypertriglyceridemia induced by S-1: Subsequent case series of four patients and further review of the literature.
    Saito Y; Takekuma Y; Takeuchi S; Komatsu Y; Sugawara M
    Int J Clin Pharmacol Ther; 2021 Dec; 59(12):787-793. PubMed ID: 34503646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report.
    Saito Y; Takekuma Y; Yuki S; Komatsu Y; Sugawara M
    Case Rep Oncol; 2021; 14(1):207-211. PubMed ID: 33776705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1.
    Elasmar SA; Saad ED; Hoff PM
    Jpn J Clin Oncol; 2001 Apr; 31(4):172-4. PubMed ID: 11386466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
    Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
    Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
    Bar-Sela G; Haim N
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-1-Associated Hypertriglyceridemia in a Patient With Pancreatic Adenocarcinoma.
    Chen HW; Kuo HY; Chen BB; Tien YW; Kuo SH; Yang SH
    JCO Oncol Pract; 2020 Jan; 16(1):45-47. PubMed ID: 31618087
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
    Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
    Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.
    Sueda T; Kudo T; Sakai D; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Ezoe S; Matsumoto K; Doki Y; Mori M; Satoh T
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1321-4. PubMed ID: 25374410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
    Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
    Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
    Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of alternate-day treatment with TS-1
    Nishiyama Y; Fukuyama Y; Maruo T; Yoda S; Iwano M; Kawarai S; Kayanuma H; Orito K
    J Vet Med Sci; 2021 Aug; 83(8):1206-1211. PubMed ID: 34148911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
    Matsuda K; Namiki T; Ueno M; Hashimoto T; Hanafusa T; Yokozeki H
    Eur J Dermatol; 2017 Jun; 27(3):323-325. PubMed ID: 28414195
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil and oteracil potassium) for colorectal cancer.
    Kawahara H; Watanabe K; Ushigome T; Noaki R; Kobayashi S; Yanaga K
    Hepatogastroenterology; 2012; 59(113):134-7. PubMed ID: 22251528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Case of Reversible Cardiac Dysfunction Associated with Tegafur/Gimeracil/Oteracil (S-1) Therapy.
    Oyakawa T; Hua Z; Ebihara A; Shiga T
    Int Heart J; 2021 May; 62(3):700-705. PubMed ID: 33994512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
    Muneoka K; Shirai Y; Yokoyama N; Wakai T; Hatakeyama K
    Int J Clin Oncol; 2005 Dec; 10(6):441-3. PubMed ID: 16369751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
    Koda K; Miyauchi H; Kosugi C; Kaiho T; Takiguchi N; Kobayashi S; Maruyama T; Matsubara H;
    Anticancer Res; 2016 Oct; 36(10):5325-5331. PubMed ID: 27798895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Importance of Medication History Management by Hospital and Community Pharmacists for Oral Anticancer Drug S-1(Tegafur/Gimeracil/Oteracil Potassium)--A Retrospective Study].
    Maeda M; Saito Y; Makino Y; Iwase H; Hayashi Y
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):79-83. PubMed ID: 26809530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
    Sakata Y; Ohtsu A; Horikoshi N; Sugimachi K; Mitachi Y; Taguchi T
    Eur J Cancer; 1998 Oct; 34(11):1715-20. PubMed ID: 9893658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.